All Healthcare articles – Page 4
-
White papersVaccinations and Boosters; the U.S. Food and Drug Administration (FDA) Makes a Strong Statement
We thought it would be helpful to opine on conflicting data with respect to the potential protection afforded by natural immunity versus that derived from vaccination, as well as the recent FDA decision to recommend COVID-19 boosters for those over 65 years of age and/or at high risk of severe COVID-19.
-
White papersBrace Yourself for the Pivot from COVID to Climate
The pandemic forced governments to plow resources into consumption, but climate challenges will require lots (and lots) of investment.
-
Research ReportImpact Opportunities - Impact Annual Report, 2020
Covid-19 has resulted in a paradigm shift: it has thrown into sharp focus the need for resilient healthcare systems and supply chains, while also highlighting the climate change crisis and workers’ rights issues.
-
White papersHow Big Data Casts New Light on Reopening Stocks
Our recent work on the COVID-19 Delta variant not only reminds us that data science can give us insights into the pandemic, but also about the ways alternative data need to be marshaled to provide actionable information for our investment views.
-
White papersThe ABCs of the Delta Variant: Anxiety, Boosters and Communication
In an effort to bring timely insights during these uncertain times, we are pleased to share an update from Terri Towers, PhD, Senior Healthcare Analyst, who shares her views on the COVID-19 (“Coronavirus”) pandemic.
-
White papersTrading the Vaccine Curve
Today, as many economies approach the final stages of their COVID-19 vaccination programs, unlocking activity hard hit by lockdowns, their experience provides an important guide for investors as to how other countries, further behind with their vaccination programs, may perform in coming quarters.
-
White papersEngaging with the animal health sector to prevent the next public health crisis
Dr Emma Berntman sets outs the gravity of AMR risk, why a multistakeholder approach is crucial and the findings from the FAIRR initiative’s latest report we have contributed to.
-
White papersGravity’s Pull Isn’t Strong Enough Yet
While fears of a COVID resurgence impacting activity and premature monetary policy tightening are weighing on markets’ outlook, momentum in the economic recovery is set to keep growth from succumbing to the pull of gravity.
-
White papersGravity Will Not Prevail–At Least Not Yet
In advanced economies, storefronts have opened, effective vaccines are rolling out, and people are ready to return to “life as we knew it.” However, normalcy will not return until the pandemic is over globally—unless borders remain closed, with unknown collateral damage.
-
White papersHow can we tackle the effects of air pollution on human health?
The quality of the air we breathe can have a significant impact on our health. Alex Bernhardt explores the climate change-driven causes of air pollution and how to tackle the problem.
-
White papersAdapt to Change
The NB Global Sustainable Equities team invests in companies that do no harm, have a durable competitive position and are adaptive to change.
-
White papersThe Great Reset: Rethinking Globalization
The COVID-19 pandemic has provided a unique opportunity to reset and rethink our approach for a better future.
-
White papersStop-and-Go Economy Refuses to be Stopped
If last year’s life-under-a-pandemic experience was unusual for every human on the planet, this year’s recovery stands apart in the history of recoveries.
-
White papersShifts & Narratives #5 - A unique crisis that opens the way to multiple regime shifts
The Covid-19 crisis is exceptional in many ways. It is the most serious health crisis since the Spanish flu a century ago. This crisis resulted in an unprecedented contraction of activity in 2020 and in the deepest global recession since World War II.
-
White papersMedical miracle: Health care innovation saves the world
Several drug developers brought COVID-19 vaccines from initial trials to people’s arms in less than a year. This lightning quick pace defied the expectations of health care professionals and saved countless lives. It was far faster than the development of any similar drug.
-
White papersWill the planets align for a green and energy transition?
Sycomore AM believes that through a combination of increased collective awareness, technological innovation and an enhanced regulatory landscape, the planets can align to ensure a meaningful and durable transition. But will they?
-
PodcastThe mindful investor
Can investment professionals benefit from approaching their working day more mindfully? Could mindfulness hold the key to reducing work-related stress while boosting productivity and making us better colleagues? To find out more, tune in to the latest episode of Fundamentals.
-
White papersAsset Class Return Forecasts - Q2 - 2021
With vaccination programs worldwide well underway, the spotlight has shifted now to the nature of the economic recovery.
-
White papersGlobal Asset Allocation Viewpoints 2Q 2021: Investing through the pandemic
The first quarter launched 2021 on a positive note. Risk markets ignored short-term economic setbacks and outperformed in anticipation of additional fiscal stimulus and widespread vaccine distribution.
-
White papersMarket Scenarios and Risks - May 2021
We note progress on the vaccine front despite logistics and side effects issues. In our central scenario, equities outperform on the back of abundant liquidity, improving fundamentals and accommodative monetary policy.
